產(chǎn)品詳情
簡單介紹：
Anti-SPLUNC3抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-SPLUNC3抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-SPLUNC3
Cat. Number:
Anti-SPLUNC3抗體KL-17681R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SPLUNC3 is a 254 amino acid protein belonging to the Plunc family. SPLUNC3 is expressed as two isoforms produced by alternative splicing events. The gene that encodes SPLUNC3 maps to human chromosome 20, which comprises approximately 2% of the human genome. Chromosome 20 contains nearly 63 million bases that encode over 600 genes, some of which are associated with Creutzfeldt-Jakob disease,Anti-SPLUNC3抗體amyotrophic lateral sclerosis, spinal muscular atrophy, ring chromosome 20 epilepsy syndrome and Alagille syndrome. Additionally, chromosome 20 contains a region with numerous genes which are thought important for seminal production and may be potential targets for male contraception.
Also known as:
BPI fold-containing family A member 3; BPIA3_HUMAN; BPIFA3; Chromosome 20 open reading frame 71; lung and nasal Anti-SPLUNC3抗體epithelium carcinoma-associated protein 3; Short long palate lung and nasal epithelium carcinoma associated 3; Short palate; SPLUNC3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human SPLUNC3.
●
Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-SPLUNC3抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-SPLUNC3抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-SPLUNC3抗體
Optimal working dilutions must be determined by the end user.
